David P Bonita

CIK 1572451 · last filed 2026-06-10

David P Bonita is a corporate insider who has filed 74 SEC Form 4 insider transactions across 12 companies since 2013. The most recent filing, for PRLD, was dated Jun 10, 2026. Across all open-market trades the lifetime net is +$26.5M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $92.9M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$92.87M

Companies

12

Total Filings

74

Lifetime Open-Market Net

$26.49M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PRLD Director 1,126,126 $4.49 $5.06M $41.00M 10 2026-06-10
IMA Director 753,441 $5.62 $4.23M $2.50M 2 2026-04-16
Repare Therapeutics Inc. (RPTX) Delisted Director 3,177,041 $2.65 $8.42M $11.29M 11 2024-06-20
Third Harmonic Bio, Inc. (THRD) Delisted Director 5,779,071 $5.38 $31.09M $5.10M 5 2024-06-10
ImageneBio, Inc. (IKNA) Delisted Director 157,288 $17.16 $2.70M $12.42M 9 2024-06-10
Acutus Medical, Inc. (AFIB) Delisted Director 1,698,183 $0.09 $152.8K $22.47M 6 2023-06-15
Tricida, Inc. (TCDA) Delisted Director 9,274,110 $0.11 $1.00M -$47.11M 9 2022-11-25
IMRA Director 4,199,068 $17.02 $71.47M $35.00M 5 2022-06-03
SIBN Director 785,368 $15.42 $12.11M $3.00M 1 2018-10-19
ViewRay, Inc. (VRAY) Delisted Director 115,613 $0.03 $2.9K $4.35M 4 2018-04-25
Loxo Oncology, Inc. (LOXO) Delisted Director 941,000 -$69.20M 9 2017-12-12
AMBIT BIOSCIENCES CORP (AMBI) Delisted Director 13,947 $0.54 $7.5K $5.66M 2 2013-05-24

Recent Filings

74 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-06-10 PRLD Grant (A) $0 EDGAR
2026-04-23 PRLD Buy (P) +2,815,315 $12.50M EDGAR
2026-04-16 IMA Buy (P) $0 EDGAR
2025-08-14 Other (J) −5,779,071 $0
2025-07-30 IMA Mixed +83,990 $2.50M EDGAR
2025-06-13 PRLD Grant (A) $0 EDGAR
2024-06-20 Repare Therapeutics Inc. (RPTX) Delisted Grant (A) $0 EDGAR
2024-06-18 PRLD Grant (A) $0 EDGAR
2024-06-10 Third Harmonic Bio, Inc. (THRD) Delisted Grant (A) $0 EDGAR
2024-06-10 ImageneBio, Inc. (IKNA) Delisted Grant (A) $0 EDGAR
Showing 110 of 74
Page 1 of 8
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.